Smartleaf Asset Management’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$3.01M Buy
6,264
+284
+5% +$154K 0.11% 167
2025
Q4
$3.49M Buy
5,980
+861
+17% +$487K 0.13% 142
2025
Q3
$2.37M Buy
5,119
+1,284
+33% +$598K 0.15% 148
2025
Q2
$1.57M Sell
3,835
-1,521
-28% -$636K 0.14% 171
2025
Q1
$2.68M Buy
5,356
+356
+7% +$193K 0.26% 80
2024
Q4
$2.59M Buy
5,000
+298
+6% +$164K 0.26% 81
2024
Q3
$2.89M Buy
4,702
+907
+24% +$537K 0.35% 59
2024
Q2
$2.09M Buy
3,795
+1,484
+64% +$850K 0.34% 62
2024
Q1
$1.34M Buy
2,311
+793
+52% +$445K 0.26% 87
2023
Q4
$803K Buy
+1,518
New +$735K 0.22% 104

Other funds holding TMO

Smartleaf Asset Management's TMO Position: Q1 2026 in Review

Smartleaf Asset Management increased its Thermo Fisher Scientific (TMO) stake by 4.7% in Q1 2026, buying an estimated $154K and bringing the position to 6,264 shares worth $3.01M. The position accounts for 0.11% of the portfolio, ranked #167.

Smartleaf Asset Management first reported a position in TMO in Q4 2023 and has held it in 10 quarters since. The position peaked at $3.49M in Q4 2025. 2,590 funds tracked by Wall St. Rank hold TMO as of Q1 2026.

  • Smartleaf Asset Management held 6,264 shares of Thermo Fisher Scientific worth $3.01M as of Q1 2026.
  • Smartleaf Asset Management bought 284 Thermo Fisher Scientific shares in Q1 2026, an estimated $154K.
  • Thermo Fisher Scientific made up 0.11% of Smartleaf Asset Management's portfolio in Q1 2026, its #167 holding.
  • Smartleaf Asset Management first reported a position in Thermo Fisher Scientific in Q4 2023 and has held it in 10 quarters since.
  • Smartleaf Asset Management's Thermo Fisher Scientific position peaked at $3.49M in Q4 2025.
  • 2,590 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.

Based on Smartleaf Asset Management's 13F filing for Q1 2026, filed 15 May 2026.